| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥12.0B | ¥11.4B | +5.0% |
| Operating Income | ¥0.7B | ¥-1.5B | +144.4% |
| Ordinary Income | ¥1.0B | ¥-1.5B | +167.1% |
| Net Income | ¥0.9B | ¥-1.5B | +161.8% |
| ROE | 6.1% | -11.0% | - |
FY2026 Q3 results: Revenue 12.0B yen (YoY +5.0%), Operating Income 0.7B yen (from -1.5B yen loss prior year, +144.4%), Ordinary Income 1.0B yen (from -1.5B yen loss, +167.1%), Net Income 0.9B yen (from -1.5B yen loss, +161.8%). The company achieved a turnaround from prior year losses to profitability across all profit levels. Basic EPS improved to 22.94 yen from -37.29 yen. The profit recovery was driven by gross margin maintenance at 77.4% combined with effective SG&A cost management, supplemented by non-operating contributions including 0.2B yen in foreign exchange gains. Cash position remains robust at 10.5B yen representing 47.9% of total assets, supporting a strong current ratio of 422.3%. However, working capital efficiency shows significant weakness with inventory turnover at 431 days and cash conversion cycle extending to 464 days, indicating operational challenges in converting profits to cash despite the earnings recovery.
Revenue of 12.0B yen increased 5.0% YoY, representing modest but stable top-line growth. The revenue expansion maintained a high gross profit margin of 77.4%, translating to gross profit of 9.3B yen. Cost of sales was 2.7B yen, demonstrating the company's value-added business model in the PXB mouse business.
Operating profit improved dramatically from a loss of 1.5B yen to a profit of 0.7B yen, a swing of 2.2B yen. This recovery was achieved through SG&A expense management at 8.6B yen representing 71.7% of revenue. The improvement in operating margin to 5.7% (from negative territory) reflects structural cost adjustments and operating leverage from revenue growth, though the margin remains modest relative to the high gross margin, indicating room for further efficiency gains.
Ordinary income reached 1.0B yen compared to operating income of 0.7B yen, with the 0.3B yen difference primarily attributable to non-operating income. Foreign exchange gains of 0.2B yen represented a significant contribution, accounting for approximately 26.2% of operating income. Interest income of 0.1B yen also contributed positively. The forex contribution suggests currency tailwinds played a material role in the profit recovery, introducing variability risk from exchange rate fluctuations.
Net income of 0.9B yen resulted from profit before tax of 1.0B yen and income tax expense of 0.1B yen, yielding an effective tax rate of approximately 10%. The low tax burden reflects either tax loss carryforwards (consistent with retained earnings of -19.4B yen indicating accumulated deficits) or other tax benefits. The gap between ordinary income and net income was minimal, indicating no material extraordinary items impacted the bottom line this period.
The performance pattern represents revenue up/profit up, with turnaround from losses to profitability across all levels. The recovery was driven by maintained gross margins, controlled operating expenses, and favorable non-operating factors including forex gains. However, the sustainability of profit improvement warrants monitoring given the material contribution from currency movements and the operational challenges reflected in working capital metrics.
The company operates a single segment (PXB Mouse Business) and therefore segment-level analysis is not applicable.
[Profitability] ROE 6.1% shows positive return generation after prior period losses, though below industry median levels. Operating margin 5.7% improved substantially from negative territory but remains modest relative to gross margin of 77.4%, suggesting opportunity for further SG&A efficiency. Net profit margin of 7.8% benefited from non-operating income including forex gains. DuPont decomposition reveals ROE of 6.1% driven by net profit margin 7.8%, asset turnover 0.546x, and financial leverage 1.45x, with profit margin recovery being the primary improvement driver. [Cash Quality] Cash and deposits 10.5B yen provide substantial liquidity, covering short-term liabilities 10.5 times over. Operating working capital efficiency shows significant concern with Days Inventory Outstanding at 431 days and Cash Conversion Cycle at 464 days, indicating cash generation lags reported profits substantially. [Investment Efficiency] Total asset turnover 0.546x reflects capital-intensive operations with room for asset productivity improvement. Working capital turnover suggests operational inefficiencies require attention. [Financial Health] Equity ratio 69.0% demonstrates strong capital adequacy well above industry median. Current ratio 422.3% indicates robust short-term liquidity. Interest-bearing debt 2.6B yen with debt-to-equity ratio 0.17x represents conservative financial leverage. Long-term loans decreased 27.3% YoY to 1.6B yen, reducing financial burden. Net debt position is negative given cash substantially exceeds debt, providing financial flexibility.
Cash and deposits increased to 10.5B yen, accounting for 47.9% of total assets and representing a strong liquidity cushion. The substantial cash position covers current liabilities of 3.9B yen by 2.7 times, indicating no near-term liquidity concerns. Working capital stands at 12.5B yen with current assets of 16.4B yen, though the efficiency of this working capital is constrained by elevated inventory levels. Long-term loans decreased 0.6B yen or 27.3% YoY to 1.6B yen, suggesting debt repayment activity during the period that would represent a cash outflow in financing activities. The reduction in interest-bearing debt from 3.4B yen to 2.6B yen (estimated from long-term loan changes) indicates deleveraging progress. Total equity increased from 13.7B yen to 15.2B yen, with the 1.5B yen increase primarily attributable to net income of 0.9B yen and comprehensive income adjustments of 0.5B yen including foreign currency translation gains. The equity ratio improvement from 59.8% to 69.0% reflects strengthening financial position. However, retained earnings remain negative at -19.4B yen indicating historical accumulated losses, though current period profitability is reducing this deficit. The working capital metrics of 431 days inventory turnover and 60 days receivables turnover suggest that despite strong reported profits, actual cash generation from operations may be constrained by inventory buildup and collection timing.
Ordinary income of 1.0B yen versus operating income of 0.7B yen indicates non-operating net contribution of approximately 0.3B yen, representing 30% of operating income and 2.5% of revenue. The primary components comprise foreign exchange gains of 0.2B yen and interest income of 0.1B yen, with minimal non-operating expenses. The forex gain contribution of 26.2% relative to operating income suggests material earnings sensitivity to currency movements, introducing volatility risk to profit sustainability. Interest income reflects the benefit of substantial cash holdings earning returns. The composition of non-operating income shows limited recurring structural characteristics, as forex gains fluctuate with exchange rate movements. Tax expense of 0.1B yen on pre-tax profit of 1.0B yen represents an effective tax rate of approximately 10%, likely reflecting utilization of tax loss carryforwards from historical deficits as evidenced by negative retained earnings. The low tax burden enhances net income but will normalize as loss carryforwards are exhausted. Comprehensive income of 1.4B yen exceeded net income of 0.9B yen by 0.5B yen, primarily due to foreign currency translation adjustments, indicating currency effects benefited not only the P&L but also balance sheet valuations. The significant working capital inefficiencies with 431-day inventory cycle and 464-day cash conversion cycle raise concerns about earnings quality, as extended inventory holding and receivables collection periods suggest reported profits may not be converting to operating cash flow efficiently.
Full-year guidance projects revenue of 16.4B yen (YoY +6.4%), operating income of 1.1B yen, ordinary income of 1.2B yen, and EPS of 27.13 yen with zero dividend. Q3 cumulative results show revenue progress at 73.2% (12.0B yen / 16.4B yen), operating income at 61.8% (0.7B yen / 1.1B yen), and ordinary income at 81.7% (1.0B yen / 1.2B yen) versus full-year targets. Against a standard Q3 progress benchmark of 75%, revenue is tracking slightly behind at 73.2%, while operating income at 61.8% suggests Q4 must contribute 0.4B yen (representing 36% of full-year target) to meet guidance. The operating income achievement rate being 13 percentage points below the standard 75% benchmark indicates backend-weighted profit expectations or potential achievement risk. Ordinary income progress of 81.7% is ahead of schedule, though this benefits from non-recurring forex gains that may not repeat at the same magnitude in Q4. The guidance implies Q4 revenue of 4.4B yen and operating income of 0.4B yen, with operating margin expected to decline to approximately 9% in Q4 compared to Q3 cumulative 5.7%, suggesting seasonal strength or cost recovery assumptions. The forecast notes indicate projections are based on currently available information and reasonable assumptions, with actual results subject to variation. No guidance revisions were announced this quarter, suggesting management confidence in the trajectory despite the modest underperformance in operating income progress rate.
Annual dividend forecast is 0.00 yen with no dividend payments planned for the current fiscal year. The company maintains a zero dividend policy with no payout ratio applicable. This approach is consistent with prioritizing internal investment, balance sheet strengthening, and working capital management given the operational challenges reflected in extended cash conversion cycles. The negative retained earnings of -19.4B yen indicate historical accumulated losses that may constrain dividend capacity from a legal and financial perspective, though current period profitability is gradually reducing this deficit. No share buyback activity was disclosed for the period. Total shareholder returns therefore remain at zero for this fiscal year. The capital allocation strategy appears focused on operational improvement and debt reduction (evidenced by 27.3% decrease in long-term loans) rather than immediate shareholder distributions, which is appropriate given the turnaround phase and working capital optimization requirements.
Business concentration risk: The company operates a single business segment (PXB Mouse Business) with no segment diversification, creating significant exposure to demand fluctuations, regulatory changes, or competitive dynamics specific to this specialized market. Revenue volatility or customer concentration within this single segment could materially impact overall performance with no offsetting business lines.
Working capital and inventory risk: Days Inventory Outstanding of 431 days represents an extremely elevated inventory cycle, indicating potential obsolescence risk, demand forecasting challenges, or production-sales mismatches. This ties up substantial capital (inventory levels implicit in DIO calculation suggest multiple quarters of supply), exposes the company to inventory valuation risk, and constrains cash flow generation despite reported profitability. The 464-day cash conversion cycle compounds this concern.
Foreign exchange exposure risk: Forex gains of 0.2B yen contributed 26.2% of operating income this period, indicating material earnings sensitivity to currency movements. The business appears to have significant foreign currency exposure (likely USD or other currencies in overseas transactions), and adverse exchange rate movements could reverse the profit improvement. The foreign currency translation adjustment of 0.5B yen in comprehensive income suggests balance sheet currency exposure as well, creating both P&L and equity volatility risk.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the IT & Telecom sector context based on benchmark data provided, though as a specialized life science company (PXB mouse business), direct sector comparisons require contextual interpretation.
Profitability: ROE 6.1% falls below the industry median of 8.3% (Q3 2025), positioning in the lower half of peers. Operating margin 5.7% is substantially below the industry median of 8.2%, suggesting room for operational efficiency improvement. Net profit margin 7.8% exceeds the industry median of 6.0%, though this benefit partially reflects non-operating forex gains and favorable tax effects rather than core operating performance.
Financial Health: Equity ratio 69.0% significantly exceeds the industry median of 59.2%, demonstrating superior capital strength and conservative financial positioning. Current ratio 422.3% far surpasses the industry median of 2.15x, indicating exceptional liquidity though potentially inefficient capital deployment. Net debt position is negative (cash exceeds debt), comparing favorably to industry median Net Debt/EBITDA of -2.84, confirming strong financial flexibility.
Efficiency: Asset turnover 0.546x trails the industry median of 0.67x, indicating lower asset productivity. Inventory turnover at 431 days is dramatically worse than the industry median of 16.51 days, representing a significant operational efficiency gap. Receivables turnover of 60 days is within reasonable range of the industry median of 61.25 days. Operating working capital turnover at 464 days (implied by CCC) substantially exceeds the industry median of 45.15 days, highlighting working capital management as a critical improvement area.
Growth: Revenue growth of 5.0% YoY lags the industry median of 10.4%, suggesting below-average market share gains or end-market exposure. EPS growth of 161.5% (turnaround from losses) significantly exceeds the industry median growth of 22%, though this reflects recovery from a depressed base rather than sustainable growth trajectory.
The company demonstrates financial strength through superior capitalization and liquidity but underperforms on operational efficiency metrics particularly inventory management and asset turnover. Profitability margins lag sector medians despite high gross margins, indicating cost structure optimization opportunities.
※ Industry: IT & Telecom (104 companies), Comparison: 2025-Q3 benchmarks, Source: Proprietary analysis
Successful turnaround execution with return to profitability: The company achieved a significant turnaround from operating losses of 1.5B yen in the prior year to operating profit of 0.7B yen, demonstrating effective cost restructuring and margin recovery. This represents a fundamental improvement in the business model's viability, with operating margin turning positive at 5.7% and net profit margin reaching 7.8%. The structural improvement is evidenced by maintained gross margins at 77.4% while achieving operating leverage through SG&A management at 71.7% of revenue. However, sustainability requires monitoring given material contributions from forex gains (26.2% of operating income) and favorable tax effects. The progress toward full-year guidance with revenue 73.2% achieved and ordinary income 81.7% achieved by Q3 suggests the turnaround trajectory is intact, though Q4 execution remains critical particularly for operating income where progress lags at 61.8%.
Critical working capital efficiency challenges requiring resolution: Despite earnings improvement, the company faces severe working capital management issues with inventory turnover at 431 days and cash conversion cycle at 464 days, dramatically underperforming the industry median of 16.51 days and 45.15 days respectively. This suggests reported profits are not efficiently converting to cash, creating operational risk and capital inefficiency. The extended inventory cycle implies potential demand forecasting issues, production-sales mismatches, or inherent business model characteristics requiring strategic attention. Receivables turnover at 60 days is reasonable, indicating the primary challenge lies in inventory management rather than collection. The working capital intensity constrains the company's ability to self-fund growth or return capital to shareholders despite returning to profitability. Resolution of these operational metrics represents a critical value creation opportunity and is essential for sustainable cash flow generation to support the earnings improvement.
Strong financial position provides strategic flexibility despite accumulated deficits: The company maintains exceptional financial health with equity ratio of 69.0% (well above industry median 59.2%), current ratio of 422.3%, and cash holdings of 10.5B yen covering short-term liabilities 10.5 times. Interest-bearing debt has been reduced 23.5% to 2.6B yen with long-term loans down 27.3% to 1.6B yen, demonstrating deleveraging progress and minimal financial risk. The robust balance sheet provides strategic flexibility to address operational challenges, invest in working capital optimization, and weather business volatility. However, retained earnings of -19.4B yen reflect historical accumulated losses that legally and practically constrain dividend capacity despite current profitability. The zero dividend policy appears appropriate given the need to rebuild retained earnings and optimize operations. The strong liquidity position combined with modest leverage (debt-to-equity 0.17x) positions the company to self-fund operational improvements and strategic initiatives without financial constraint, though capital efficiency metrics suggest the substantial cash holdings may be underutilized rather than strategically deployed.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.